{"id":"W4384926029","doi":"10.2217/fon-2023-0436","title":"Time to Next Treatment in Patients with Chronic Lymphocytic Leukemia Initiating First-Line Ibrutinib or Acalabrutinib","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Internal medicine; Oncology; Hazard ratio; Pharmacy; Leukemia; Confidence interval; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00153455,0.0001973342,0.000372068,0.0005296059,0.0002976441,0.001006719,0.000340682,0.0005115423,0.002693671],"category_scores_gemma":[0.007224865,0.0001705477,0.0006381785,0.0008050883,0.0001885382,0.0009527017,0.0003906636,0.0008259152,0.00030969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007497414,"about_ca_system_score_gemma":0.0005098819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002601631,"about_ca_topic_score_gemma":0.003885449,"domain_scores_codex":[0.9985749,0.0005351435,0.0001648522,0.0003261746,0.0001964695,0.0002025177],"domain_scores_gemma":[0.9913188,0.002551556,0.00521579,0.0001984954,0.0002355941,0.000479741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001550127,0.0001453587,0.9903064,0.00005841296,0.0001548895,0.00006302638,0.00006624582,0.0002549236,0.0001183095,0.00006479157,0.0003185296,0.006899054],"study_design_scores_gemma":[0.0001332654,0.001050374,0.9940691,0.00005274729,0.0001638113,0.0004933709,0.0002588727,0.001800224,0.0003194076,0.0001421615,0.001495277,0.00002142908],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9955527,0.001282439,0.0002281611,0.0002019759,0.00002002479,0.00002989541,0.001381201,0.000008516074,0.00129502],"genre_scores_gemma":[0.9979939,0.0003143705,0.0001815215,0.00009247308,0.00002771138,0.00002926559,0.001119897,0.000003532008,0.0002373158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002693671,"threshold_uncertainty_score":0.009011269,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02862538190468888,"score_gpt":0.3218995280787459,"score_spread":0.2932741461740571,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}